Blog

Happy birthday BioRadon! – European Organisation for Research and Treatment of Cancer (EORTC)

Photo taken from EORTC/LinkedIn.

Oct 6, 2023, 16:28

Happy birthday BioRadon! – European Organisation for Research and Treatment of Cancer (EORTC)

Quoting European Organisation for Research and Treatment of Cancer (EORTC) on LinkedIn:

“Happy birthday BioRadon!

Today, we celebrate the second anniversary of the opening of this EORTC study investigating correlations between radon exposure at home and molecular alterations in patients with all stages of non-small cell lung cancer.

The BioRadon project has received funding from the European Commission, Ligue contre le cancer, Eli Lilly and Company, Novartis, BeiGene and AUREUS ARS ET SCIENTIA ASBL.

Bioradon is a SPECTA platform downstream project. The SPECTA platform is supported by Alliance Healthcare, a member of Cencora.”

For more information click here.
Source: European Organisation for Research and Treatment of Cancer (EORTC)/LinkedIn.

AUREUS ARS ET SCIENTIA ASBL BeiGene Bioradon cancer Eli Lilly EORTC - European Organisation for Research and Treatment of Cancer European Commission Ligue contre le cancer non small cell lung cancer Novartis OncoDaily Oncology SPECTA

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage